FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to formula compounds and their pharmaceutically acceptable salts, where A represents C(R1); D represents N(R2); E represents N; G are selected from group, consisting of R71-O-C(O)- and R72-N(R73)-C(O)-; R1 are selected from hydrogen, halogen and (C1-C6)-alkyl; R2 are selected from (C1-C7)-alkyl, (C3-C7) cycloalkyl-CsH2s- and Ar-CsH2s-, where s equals 0, 1, 2 and 3; R10 are selected from R11-O-, R12-N(R13)-C(O)-O- and Het2-C(O)-O-; R11 are selected from hydrogen, R14, (C3-C7)-cycloalkyl and Ar; R12 and R13 independently on each other are selected from hydrogen, R15 and Ar; R14 represents (C1-C10)-alkyl, which is optionally substituted with 1-3 similar or different substituents, selected from halogen, HO-, R16-O-, oxo, (C3-C7)-cycloalkyl, optionally substituted with 1-3 fluorine atoms, Ar, Het1, Het3, di((C1-C4)-alkyl)N-C(O)- and Het1-C(O)-; R15 represents (C1-C6)-alkyl; R16 represents (C1-C6)-alkyl, which is optionally substituted with (C1-C4)-alkyl-O-; R30 is selected from group, consisting of R31, R32-CuH2u- and Het3-CuH2u-, where u equals 0; R31, R32 and R33 are such as given in invention formula; R40 represents hydrogen; R30 and R40 together represent (CH2)x, x equals 2, 3, 4 or 5; R50 is selected from group, consisting of hydrogen and HO-; R60 represents hydrogen; R71, R72 and R73 are such as given in invention formula; Ar is selected from group, consisting of phenyl and aromatic 6-membered monocyclic heterocycle, which includes one nitrogen atom, with phenyl and heterocycle being optionally substituted with 1-3 similar or different substituents, selected from halogen (C1-C6)-alkyl, optionally substituted with 1-3 fluorine atoms, (C1-C6)-alkyl-O-, (C1-C6)-alkyl-S(O)m-, H2N-S(O)2- and NC-; Het1, Het2, Het3 and Het4 are such as given in invention formula; m equals 0, 1 and 2. Invention also relates to method of obtaining formula I compounds, pharmaceutical composition and application.
EFFECT: formula I compounds, possessing properties of cathepsin A protease.
2 cl, 2 tbl, 762 ex
Title | Year | Author | Number |
---|---|---|---|
SUBSTITUTED DERIVATIVES OF 3-THIAZOLAMINEPROPIONIC ACID AND THEIR USE AS PHARMACEUTICALS | 2012 |
|
RU2617843C2 |
SUBSTITUTED DERIVATIVES OF 3-HETEROAROYLAMINOPROPIONIC ACID AND THEIR APPLICATION AS DRUGS | 2012 |
|
RU2632897C2 |
AMINO-SUBSTITUTED 3-HETEROAROYLAMINO-PROPIONIC ACID DERIVATIVES AND USE THEREOF AS PHARMACEUTICAL AGENTS | 2012 |
|
RU2605600C2 |
PYRROLO- AND THIAZOLOPYRIDINE COMPOUNDS (VERSIONS) AND BASED PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2461557C2 |
PYRAZOLOPYRIDINE DERIVATIVES AS NADPH-OXIDASE INHIBITORS | 2009 |
|
RU2538041C2 |
PYRAZOLOPYRIDINE DERIVATIVES AS NADPH OXIDASE INHIBITORS | 2009 |
|
RU2532161C2 |
PHENOXYMETHYL DERIVATIVES | 2016 |
|
RU2746481C1 |
ANTIBACTERIAL AGENT | 2000 |
|
RU2269525C2 |
PRODRUG 1,3-DIAMINO-2-HYDROXYPROPANE DERIVATIVES | 2003 |
|
RU2357962C2 |
SUBSTITUTED THIOPHENECARBOXAMIDES AND ANALOGUES AS ANTIBACTERIAL AGENTS | 2019 |
|
RU2797316C2 |
Authors
Dates
2015-08-20—Published
2011-01-26—Filed